XRA 5 Corp. /
Mural
XRA 5 Corp. to acquire Mural in cash transaction
Source for the buyer and target: Mural Oncology plc
For the buyer and target.
“As previously announced, on August 20, 2025, Mural entered into a Transaction Agreement (the “Transaction Agreement”), by and among Mural, XOMA Royalty Corporation, a Nevada corporation (“Bidder”), and XRA 5 Corp., a Delaware corporation and wholly-owned subsidiary of Bidder (“Sub”).”
Published 12 Sep 2025
Open the sourceWhat happened
XRA 5 Corp., a subsidiary of XOMA Royalty Corporation, has agreed to acquire Mural through a scheme of arrangement. The agreement was entered into on Aug. 20, 2025. [01]
Mural shareholders are entitled to a base cash price of $2.035 per share, with the possibility of an additional amount of up to $0.205 per share. [01]
The source
Everything on this page comes from the source below, quoted word for word.
XRA 5 Corp. to acquire Mural in cash transaction
This document is the source for the companies, stage, figure and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly